Renata De Maria Selected Research

Anterior Wall Myocardial Infarction

1/2018	Galectin-3 and outcomes after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
1/2017	Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renata De Maria Research Topics

Disease

37	Heart Failure 05/2022 - 12/2002
3	Obesity 06/2021 - 01/2020
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	COVID-19 11/2020 - 10/2020
3	Left Ventricular Dysfunction 07/2019 - 09/2007
3	Systolic Heart Failure 12/2008 - 05/2006
2	Pneumonia (Pneumonitis) 11/2020 - 11/2020
2	Insulin Resistance 01/2020 - 01/2020
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2018 - 07/2007
2	Anterior Wall Myocardial Infarction 01/2018 - 01/2017
2	Coronary Disease (Coronary Heart Disease) 01/2018 - 03/2012
2	ST Elevation Myocardial Infarction 01/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 04/2015 - 05/2010
2	Hyperemia 10/2014 - 04/2013
2	CADASIL 10/2014 - 01/2013
1	Magnesium Deficiency (Deficiency, Magnesium) 01/2020
1	Fatty Liver 01/2020
1	Acute Coronary Syndrome 05/2019
1	Malnutrition (Nutritional Deficiencies) 04/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2018
1	Myocarditis (Carditis) 04/2018
1	Ventricular Remodeling 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 06/2017
1	Olfaction Disorders (Cacosmia) 11/2016
1	Parkinson Disease (Parkinson's Disease) 11/2016
1	REM Sleep Behavior Disorder 11/2016
1	Autonomic Nervous System Diseases (Dysautonomia) 11/2016
1	Cachexia 04/2015
1	Hypercapnia 04/2015
1	Hypoxia (Hypoxemia) 04/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2015
1	Disease Progression 04/2015
1	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2016
5	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2019 - 05/2006
4	Glutathione (Reduced Glutathione)IBA 01/2021 - 09/2006
4	Cysteine (L-Cysteine)FDA Link 01/2021 - 04/2007
4	DiureticsIBA 12/2018 - 06/2003
4	Sulfhydryl Compounds (Thiols)IBA 12/2007 - 09/2006
3	AntioxidantsIBA 01/2021 - 01/2013
3	Natriuretic PeptidesIBA 01/2021 - 10/2013
2	NeopterinIBA 06/2021 - 07/2010
2	Oxidants (Oxidizing Agents)IBA 01/2021 - 01/2013
2	HomocysteineIBA 01/2021 - 04/2007
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2020 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 05/2014
2	Galectin 3 (LGALS3)IBA 01/2018 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 11/2005
2	InterleukinsIBA 04/2013 - 07/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2013 - 10/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 12/2007
2	CytokinesIBA 07/2010 - 10/2007
2	Malondialdehyde (Propanedial)IBA 04/2007 - 09/2006
1	MyostatinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	LeptinIBA 01/2021
1	AdiponectinIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Calcineurin InhibitorsIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	MagnesiumIBA 01/2020
1	Enalapril FDA LinkGeneric 10/2018
1	Pharmaceutical PreparationsIBA 10/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2018
1	Neprilysin (Neutral Endopeptidase)IBA 10/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2018
1	ProlactinIBA 04/2018
1	Tocolytic Agents (Tocolytics)IBA 04/2018
1	oxidized low density lipoproteinIBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Biological ProductsIBA 11/2016
1	SodiumIBA 01/2016
1	Oxygen (Dioxygen)IBA 04/2015
1	Genetic Markers (Genetic Marker)IBA 12/2014
1	sapropterin (tetrahydrobiopterin)FDA Link 10/2014
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	3-nitrotyrosineIBA 01/2013

Therapy/Procedure

9	Therapeutics 05/2022 - 07/2009
5	Heart-Assist Devices 05/2022 - 07/2010
3	Heart Transplantation (Grafting, Heart) 05/2022 - 01/2016
3	Cardiac Rehabilitation 02/2019 - 03/2015
3	Cardiac Resynchronization Therapy 10/2018 - 10/2012
3	Patient Readmission 10/2015 - 05/2005
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2012 - 08/2003
2	Defibrillators (Defibrillator) 10/2020 - 02/2010
2	Ambulatory Care (Outpatient Care) 05/2019 - 07/2016
2	Percutaneous Coronary Intervention 01/2018 - 01/2017
2	Continuity of Patient Care 01/2016 - 05/2010
2	Palliative Care (Palliative Therapy) 04/2015 - 12/2012
1	Critical Care (Surgical Intensive Care) 05/2019
1	Secondary Prevention 01/2018
1	Continuous Positive Airway Pressure 06/2017
1	Noninvasive Ventilation 06/2017
1	Length of Stay 10/2015